Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,634 | 40,320 | 43,054 | 51,184 | 13,269 |
| Receivables | 12,884 | 12,908 | 12,312 | 10,274 | 8,814 |
| Inventories | 1,060 | 1,125 | 2,144 | 2,064 | 2,156 |
| Other current assets | 466 | 546 | 283 | 161 | 44 |
| TOTAL | $44,124 | $57,965 | $62,172 | $68,171 | $26,858 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 822 | 956 | 989 | 1,022 | 6 |
| TOTAL | $822 | $956 | $989 | $1,022 | $6 |
| Total Assets | $44,946 | $58,921 | $63,161 | $69,193 | $26,864 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 252 | N/A |
| Accounts payable and accrued liabilities | 3,241 | 3,867 | 4,447 | 5,204 | 3,778 |
| Accrued Expenses | 3,428 | 3,313 | 3,038 | 4,363 | 3,754 |
| Other current liabilities | 248 | 248 | 252 | N/A | N/A |
| TOTAL | $6,919 | $7,435 | $7,749 | $9,836 | $7,553 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,067 | 29,773 | 29,753 | 29,732 | 29,712 |
| Other Non-Current Liabilities | 25,832 | 26,884 | 27,016 | 26,611 | 1,221 |
| TOTAL | $43,899 | $56,657 | $56,769 | $56,343 | $30,933 |
| Total Liabilities | $50,818 | $64,092 | $64,518 | $66,179 | $38,486 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,594 | 27,432 | 27,364 | 27,322 | 27,100 |
| Common Shares | 145,608 | 145,438 | 145,281 | 144,934 | 144,307 |
| Retained earnings | -219,681 | -217,696 | -211,961 | -206,408 | -219,245 |
| Other shareholders' equity | 1,243 | 1,243 | 1,243 | 1,243 | 1,243 |
| TOTAL | $-5,872 | $-5,171 | $-1,357 | $3,014 | $-11,622 |
| Total Liabilities And Equity | $44,946 | $58,921 | $63,161 | $69,193 | $26,864 |